Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.

被引：111
作者：
Suzan, F
Ammor, M
Ribrag, V
机构：
[1] Inst Gustave Roussy, F-94805 Villejuif, France
[2] Hop Kremlin Bicetre, F-94270 Le Kremlin Bicetre, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2001年 / 345卷 / 13期
关键词：
D O I：
10.1056/NEJM200109273451315
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1000 / 1000
页数：1
相关论文
共 4 条
  • [1] Bermúdez A, 2000, HAEMATOLOGICA, V85, P894
  • [2] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
    Czuczman, MS
    Grillo-López, AJ
    White, CA
    Saleh, M
    Gordon, L
    LoBuglio, AF
    Jonas, C
    Klippenstein, D
    Dallaire, B
    Varns, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 268 - 276
  • [3] Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab.
    Dervite, I
    Hober, D
    Morel, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) : 68 - 69
  • [4] Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab
    Sharma, VR
    Fleming, DR
    Slone, SP
    [J]. BLOOD, 2000, 96 (03) : 1184 - 1186
1